Bill Ackman Is A Winner: Valeant Pharmaceuticals Intl Inc. (VRX), Allergan Inc. (AGN), Actavis plc (ACT)
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc.
Posts Tagged ‘Valeant Pharmaceuticals Intl Inc (VRX)’
Is Zoetis Inc (ZTS) Bill Ackman’s Back-up Plan for Valeant Pharmaceuticals Intl Inc (VRX)?
As it was previously rumored in many sources, Bill Ackman's Pershing Square took a massive position in Zoetis Inc (NYSE:ZTS), as reported in a new filing with the US Securities...
Allergan, Inc. (AGN): Bill Ackman Sends Letter Commenting on Potential Merger Deal with Actavis plc (ACT)
Bill Ackman's intentions to acquire Allergan, Inc.
Allergan Inc. (AGN) Push For Actavis plc (ACT) Merger Shunning Valeant Pharmaceuticals Intl Inc. (VRX) Hostile Bid
Bill Ackman may be failing all together on his push to get Allergan to agree to a merger agreement with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX).
Hedge Fund News: Nelson Peltz, Jim Chanos & Warren Buffett
The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board...
Hedge Fund News: Bill Ackman, Christian Leone & Valueact Capital
Bill Ackman wants to clear up a few things.
Hedge Fund News: Steven Cohen, Carl Icahn & Lansdowne Partners
The best thing federal prosecutors might have done for Steven A.
Valeant Pharmaceuticals Intl Inc (VRX): ValueAct Capital Raises Stake as Jeffrey Ubben is Appointed as Board Director
Jeffrey Ubben’s Valueact Capital Management disclosed today an increase in its exposure to Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Hedge Fund News: Marc Lasry, Warren Buffett & Marcato Capital Management
Avenue Capital Group LLC, the U.S.
Allergan Inc. (AGN) Settles Lawsuit with Pershing Square, Valeant Pharmaceuticals Intl Inc (VRX); Agrees on Calling Special Shareholders Meeting
Pershing Square, managed by Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have entered into an agreement with Allergan Inc.
Hedge Fund News: Edward Lampert, George Soros & Bill Ackman
Hedge fund ESL Investments has loaned $400 million to its largest investment, Sears Holdings Corporation (NASDAQ:SHLD), a cash infusion that will keep the struggling retailer ...
Valeant Pharmaceuticals Intl Inc (VRX) and Allergan, Inc. (AGN)’s Hostile Saga Nears Its End
On 18th December the winner of the epic corporate battle between Allergan, Inc.
Hedge Fund News: Phil Falcone, Louis Hanover & Bridgewater Associates
Minnesota Wild co-owner Phil Falcone might quit his hockey-crazed home state to make a play for the New York Islanders, The Post has learned.
Bill Ackman Sends One More Letter to Allergan, Inc. (AGN) Pushing For Company’s Sale To Valeant Pharmaceuticals Intl Inc (VRX)
Bill Ackman does not show any signs of giving up on the proposed takeover of Allergan, Inc. (NYSE:AGN) by Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Hedge Fund News: David Harding, Chris Hohn & Valueact Capital
Hedge fund boss gives £5 million to build new museum maths gallery (Standard) A hedge fund manager who built his business on mathematical reasoning has given the Science Museum...
Hedge Fund News: Bill Ackman, David Einhorn & Aurelius Capital Management
When William Ackman took the stage at the AXA Equitable Auditorium in Midtown Manhattan on April 22, investors were still digesting the news that his firm, Pershing Square Capital...
Allergan (AGN): Valeant Pharmaceuticals (VRX), Ackman Plan To Request Shareholders Meeting
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Bill Ackman’s Pershing Square Capital Management will today comply with one of Allergan, Inc.
American Airlines Group Inc (AAL), Allergan, Inc.(AGN), Ally Financial Inc (ALLY): Billionaire Jamie Dinan’s Top Stocks
Having lost all his savings on Black Monday in 1987, James Dinan made a remarkable comeback, setting up his hedge fund, York Capital Management, in 1991 with $3.6 million and...
Walgreen Company (WAG), llumina Inc. (ILMN), Valeant Pharmaceuticals Intl Inc (VRX): Billionaire Andreas Halvorsen’s Top Stock Picks
Andreas Halvorsen’s Viking Global recently disclosed its long equity positions for the second quarter of 2014. The fund declared holdings worth more than $22.9 billion.
Allergan, Inc. (AGN)’s Top Shareholders Sold The Stock Amid Takeover Talks
Allergan, Inc. (NYSE:AGN)'s stock saw a massive upside in April when it was revealed that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was trying to buy the company with the...
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX), Motorola Solutions Inc (MSI): Jeffrey Ubben’s Top Stock Picks
Jeffrey Ubben’s ValueAct Capital has disclosed its holdings for the second quarter, revealing 16 investments which have a current market value of $13.5 billion.
Baker Hughes Incorporated (BHI), Whiting Petroleum Corp (WLL), Valeant Pharmaceuticals Intl Inc (VRX): Steven Cohen’s Point72 Loves These Stocks
As previously reported, Billionaire Steven Cohen earlier this year shut down his fund SAC Capital Advisors and opened Point72 Asset Management, a fund that handles Cohen’s ...
Valeant Pharmaceuticals Intl Inc (VRX), Pershing Square Took no Steps Towards Tender Offer before Buying Allergan, Inc. (AGN) Stock: Bill Ackman
Speaking to CNBC’s Scott Wapner over the phone yesterday, investor and hedge fund manager Bill Ackman denied the allegations set forth against him and Valeant Pharmaceuticals...
Hedge Fund News: Louis Bacon, Chase Coleman & Third Point
The hedge fund billionaire Louis M.
Valeant Pharmaceuticals Intl Inc. (VRX), Carter’s Inc. (CRI), Charter Communications Inc. (CHTR) Amongst Hound Partners Top Q2 Picks
Hound Partners, managed by Jonathan Auerbach, disclosed its equity positions for the second quarter of 2014. In a new filing with the U.S.
Valeant Pharmaceuticals Intl Inc (VRX), Bill Ackman on Radars Over Allergan, Inc. (AGN) Insider Trading Scandal
Billionaire investor and hedge fund Manager Bill Ackman of Pershing Square has been in the news recently for all the wrong reasons. Allergan, Inc.
Hedge Fund News: Carl Icahn, Bill Ackman & Marcato Capital Management
Carl Icahn makes more money between sips on his outsized Martinis than most mortals make in a lifetime.
Hedge Fund News: Eric Mindich, Warren Lichtenstein & Daniel Loeb
Investors have pulled more than $1 billion from Eric Mindich's Eton Park Fund, managed by his New York-based multistrategy hedge fund firm Eton Park Capital Management, since ...
Hedge Fund News: Stanley Druckenmiller, John Paulson & Starboard Value LP
The Fed is out of step with Wall Street, say some of the country’s wealthiest investors.
Hedge Fund News: Jim Simons, Feroz Dewan & Soros Fund Management
Long Island hedge-fund investor James Simons and his wife have given $50 million to the Cold Spring Harbor Laboratory to establish a center that uses quantitative tools to understand...
Hedge Fund News: Ray Dalio, Paul Singer & Ken Griffin
Ray Dalio, the enigmatic, transcendentally meditating leader of one, if not the, most successful hedge funds in the country, does not tend to brag or boast about, well, anything...
Hedge Fund News: Seth Klarman, George Soros & Pershing Square
Seth Klarman's $US27 billion hedge fund Baupost has become the latest US investor to pile onto the share register of aspiring US LNG terminal developer Liquefied Natural Gas Ltd...
Hedge Fund News: Daniel Loeb, Bill Ackman & Tiger Global Management
Third Point LLC, a hedge fund controlled by activist investor Daniel Loeb, has bought more than 1 million shares of the common stock of Roper Industries, Inc. (NYSE:ROP).
Viking Global’s Top Five Picks for Q1 include Walgreen Company (WAG) & Time Warner Inc (TWX)
Last week, Andreas Halvorsen’s Viking Global, filed a Form 13F at the U.S. Securities and Exchange Commission, disclosing its equity positions as of March 31 2014.
Hedge Fund News: Ken Griffin, David Einhorn & Bill Ackman
The asset management industry is playing US regulators against their international counterparts and stirring national sentiment on Capitol Hill in an attempt to head off new regulation...
Hedge Fund News: Jim Chanos, Thomas Steyer & Carl Icahn
Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.
Hedge Fund News: Bill Ackman, Steven Heinz & Sac Capital Advisors
Three weeks ago Quebec based pharmaceuticals company Valeant Pharmaceuticals Intl Inc (NYSE:VRX) made a US$47 billion hostile takeover bid, in cash and stock, to acquire Irvine...
Hedge Fund News: Bill Ackman, Crispin Odey & David Tepper
Canada’s largest pharmaceutical company and the U.S. activist investor who overhauled CP Rail have joined forces in a mega-deal to buy Allergan, Inc.
Kenneth Squire’s 13D Management Is Betting on These Stocks
13D Management is a New-York firm that was founded by Kenneth Squire in 2011. The fund, an event driven asset manager, focused on imitating activist investors.
Iridian Asset Management’s Top Five Picks Include Valeant Pharmaceuticals Inc (VRX), Wyndham Worldwide Corporation (WYN) & Other
Hedge fund Iridian Asset Management, led by David Cohen and Harold Levy, focuses on depressed stocks that are going through significant changes.
Wallace R. Weitz & Co. Upps its Stakes in XO Group Inc (XOXO), Redwood Trust, Inc. (RWT), and Intelligent Systems Corporation (INS)
In three sepearte filings, Wallace Weitz’s Wallace R. Weitz & Co. has disclosed that it has upped its holdings in XO Group Inc (NYSE:XOXO), Redwood Trust, Inc.
Hedge Funds Are Crazy About Alkermes Plc (ALKS)
In the financial world, there are plenty of indicators shareholders can use to watch stocks. A couple of the best are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love Elan Corporation, plc (ADR) (ELN)?
Now, according to many of your fellow readers, hedge funds are seen as useless, old investment tools of a period lost to current times.
Hospira, Inc. (HSP): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
To the average investor, there are a multitude of gauges shareholders can use to analyze their holdings. Two of the most useful are hedge fund and insider trading sentiment.
Hedge Funds Are Buying Valeant Pharmaceuticals Intl Inc (VRX)
At the moment, there are tons of gauges investors can use to track Mr. Market. A duo of the most innovative are hedge fund and insider trading sentiment.
Warner Chilcott Plc (WCRX) & Actavis Inc (ACT): Can You Profit From This Pharma Tie-Up
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.
Valeant Pharmaceuticals Intl Inc (VRX): Hedge Funds and Insiders Are Bullish, What Should You Do?
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in 37 hedge funds' portfolio at the end of March.
Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT)
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
